Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Busulfan

"Busulfan" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen.


This graph shows the total number of publications written about "Busulfan" by people in Harvard Catalyst Profiles by year, and whether "Busulfan" was a major or minor topic of these publication.
Bar chart showing 87 publications over 26 distinct years, with a maximum of 12 publications in 2015
To see the data from this visualization as text, click here.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.